45.14

3.44% -1.61

Collegium Pharmaceutical Inc (COLL)

Overview News Price History Option Chain Financials Discussions Forecast

Collegium Pharmaceutical Inc stock is traded at $45.14, with a volume of 388.31K. It is down -3.44% in the last 24 hours and down -0.88% over the past month. Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Previous Close:

$46.75

Open:

$46.4

24h Volume:

388.31K

Relative Volume:

0.75

Market Cap:

$1.43B

Revenue:

$566.77M

Net Income/Loss:

$48.16M

P/E Ratio:

37.93

EPS:

1.19

Net Cash Flow:

$274.29M

1W Performance:

-6.31%

1M Performance:

-0.88%

6M Performance:

+24.90%

1Y Performance:

+42.94%

1-Day Range:

$43.99

$46.46

1-Week Range:

$43.99

$49.31

52-Week Range:

$23.23

$50.79

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Name

Collegium Pharmaceutical Inc

Sector

Healthcare (1108)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

781-713-3699

Address

100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA

Employee

357

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

COLL's Discussions on Twitter

Compare COLL vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COLL Collegium Pharmaceutical Inc	45.14	1.48B	566.77M	48.16M	274.29M	1.19
TAK Takeda Pharmaceutical Co Adr	18.28	57.18B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	128.67	56.47B	9.40B	2.65B	2.24B	5.935
HLN Haleon Plc Adr	11.16	49.16B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	34.31	40.03B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	475.85	20.37B	3.13B	1.27B	1.12B	26.39

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-25	Initiated	Barclays	Overweight
Jan-10-25	Upgrade	Needham	Hold → Buy
Jul-30-24	Upgrade	H.C. Wainwright	Neutral → Buy
Jun-07-24	Upgrade	Jefferies	Hold → Buy
May-10-24	Downgrade	Needham	Buy → Hold
May-10-24	Downgrade	Piper Sandler	Overweight → Neutral
Jan-04-24	Downgrade	Jefferies	Buy → Hold
Aug-25-23	Reiterated	Needham	Buy
May-02-23	Resumed	Jefferies	Buy
Aug-08-22	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-15-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Aug-06-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jan-11-21	Reiterated	H.C. Wainwright	Buy
Jul-14-20	Initiated	BWS Financial	Sell
May-27-20	Initiated	Guggenheim	Neutral
Feb-19-20	Resumed	Jefferies	Buy
Oct-30-19	Reiterated	Needham	Buy
May-03-19	Resumed	H.C. Wainwright	Buy
Apr-12-19	Resumed	Janney	Buy
Mar-20-19	Initiated	SunTrust	Hold
Jan-16-19	Reiterated	Needham	Buy
Mar-08-18	Reiterated	H.C. Wainwright	Buy
Feb-07-18	Reiterated	Needham	Buy
Dec-05-17	Reiterated	Needham	Buy
Sep-11-17	Initiated	H.C. Wainwright	Buy
May-11-17	Reiterated	Needham	Buy
Sep-13-16	Initiated	Gabelli & Co	Buy
Jun-01-15	Initiated	Jefferies	Buy
Jun-01-15	Initiated	Needham	Buy
Jun-01-15	Initiated	Piper Jaffray	Overweight

View All

Collegium Pharmaceutical Inc Stock (COLL) Latest News

Feb 11, 2026

Earnings Report: Whats Collegium Pharmaceutical Incs historical returnTake Profit & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Feb 11, 2026

The Truth About Collegium Pharmaceutical (COLL): Quiet Stock, Loud Moves – Are You Sleeping On Thi - AD HOC NEWS

Feb 11, 2026

Feb 10, 2026

Truist Adjusts Price Target on Collegium Pharmaceutical to $58 From $55, Maintains Buy Rating - marketscreener.com

Feb 10, 2026

Truist Securities raises Collegium Pharmaceutical stock price target to $58 - Investing.com

Feb 10, 2026

Truist Securities raises Collegium Pharmaceutical stock price target to $58 By Investing.com - Investing.com Nigeria

Feb 10, 2026

Versor Investments LP Purchases New Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat

Feb 10, 2026

Feb 05, 2026

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 05, 2026

Feb 04, 2026

COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) Presents a Classic Value Case with High Earnings and Low Valuation - Chartmill

Feb 04, 2026

Feb 02, 2026

What Collegium Pharmaceutical (COLL)'s Revenue Surge and Low Valuation Means For Shareholders - simplywall.st

Feb 02, 2026

Ballast Asset Management LP Purchases 27,109 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat

Feb 02, 2026

Feb 01, 2026

(COLL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Feb 01, 2026

Collegium Pharmaceutical: Quiet Chart, Loud Questions Around This Specialty Pain Stock - AD HOC NEWS

Feb 01, 2026

Jan 31, 2026

Market Moves: Is Collegium Pharmaceutical Inc trading at a discount2025 Market Sentiment & Growth Oriented Trade Recommendations - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026